Argenx
ARGX
#523
Rank
โ‚น3.449 T
Marketcap
โ‚น56,765
Share price
-1.58%
Change (1 day)
77.53%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Earnings for Argenx (ARGX)

Earnings in 2024 (TTM): -โ‚น5.18 Billion

According to Argenx 's latest financial reports the company's current earnings are โ‚น1.85 Billion. In 2023 the company made an earning of -โ‚น26.39 Billion, an increase over its 2022 earnings that were of -โ‚น63.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Argenx from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น5.18 Billion-80.39%
2023 -โ‚น26.39 Billion-58.25%
2022 -โ‚น63.2 Billion
2019 -โ‚น17.25 Billion124.95%
2018 -โ‚น7.67 Billion132.04%
2017 -โ‚น3.31 Billion54.86%
2016 -โ‚น2.14 Billion33%
2015 -โ‚น1.61 Billion13.63%
2014 -โ‚น1.42 Billion46.25%
2013 -โ‚น0.97 Billion